Skip to main content

Deposited paper deposited in the House of Commons and House of Lords by the Department of Health on Thursday, 6 March 2008. The commitment to deposit was made on Thursday, 6 March 2008.


Deposited Paper DEP2008-0652

I. MHRA investigation into the Glaxosmithkline and Seroxat. 15 p. II. Letter dated 06/03/2008 from Kent Woods, Chief Executive, to Richard Barker, Director General ABPI, regarding regulation of the pharmaceutical industry. III. Letter dated 06/03/2008 from Kent Woods to Jean-Pierre Garnier, Glaxosmithkline, regarding the investigation into Seroxat. 2 p.

Available files
https://data.parliament.uk/DepositedPapers/files/DEP2008-0652/DEP2008-0652.zip

Secondary information

Type
Deposited paper
Reference
DEP2008-0652 
Originated on
Thursday, 6 March 2008
Author
Department of Health
Medicines and Healthcare products Regulatory Agency
Related items
GlaxoSmithKline (MHRA Investigation)
Thursday, 6 March 2008
Written statements
House of Commons
Glaxosmithkline
Thursday, 6 March 2008
Written statements
House of Lords
Subjects
Crime Pharmacy Prescription drugs Monitoring Standards Association of the British Pharmaceutical Industry Regulation Safety GlaxoSmithKline Paroxetine